Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 11:25 am Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 840,169 6.630% | 9,183 (+1.11%) | Filing History |
| 2023-02-01 11:16 am Purchase | 2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV | FEDERATED HERMES INC. FHI | 1,201,275 22.500% | 1,201,275 (New Position) | Filing History |
| 2023-02-01 11:06 am Purchase | 2022-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,924,295 8.480% | 244,995 (+6.66%) | Filing History |
| 2023-02-01 10:58 am Purchase | 2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | FEDERATED HERMES INC. FHI | 2,864,500 5.950% | 574,218 (+25.07%) | Filing History |
| 2023-02-01 10:46 am Sale | 2022-12-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 12,640,363 9.910% | -4,142,475 (-24.68%) | Filing History |
| 2023-02-01 10:39 am Purchase | 2022-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | FEDERATED HERMES INC. FHI | 900,651 6.620% | 900,651 (New Position) | Filing History |
| 2023-02-01 10:29 am Purchase | 2022-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 5,231,600 18.030% | 5,231,600 (New Position) | Filing History |
| 2023-02-01 10:21 am Unchanged | 2022-12-31 | 13G | Aris Water Solutions, Inc. ARIS | FEDERATED HERMES INC. FHI | 2,588,600 9.760% | 0 (Unchanged) | Filing History |
| 2023-02-01 10:11 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,239,554 16.000% | 544,625 (+14.74%) | Filing History |
| 2023-02-01 10:07 am Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | FEDERATED HERMES INC. FHI | 3,057,800 6.420% | 1,032,200 (+50.96%) | Filing History |
| 2023-02-01 09:49 am Purchase | 2022-12-31 | 13G | AnaptysBio, Inc. ANAB | FEDERATED HERMES INC. FHI | 2,373,023 8.350% | 1,053,850 (+79.89%) | Filing History |
| 2023-02-01 09:43 am Sale | 2022-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,284,217 6.800% | -180,118 (-5.20%) | Filing History |
| 2023-02-01 09:41 am Purchase | 2022-12-31 | 13G | Alector, Inc. ALEC | FEDERATED HERMES INC. FHI | 4,571,660 5.530% | 4,571,660 (New Position) | Filing History |
| 2023-02-01 09:07 am Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 1,956,488 9.450% | -402,136 (-17.05%) | Filing History |
| 2023-02-01 09:03 am Purchase | 2022-12-31 | 13G | MALLINCKRODT PLC SHS MNKTQ | FEDERATED HERMES INC. FHI | 998,958 7.580% | 998,958 (New Position) | Filing History |
| 2023-02-01 08:56 am Purchase | 2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 3,224,100 7.200% | 3,224,100 (New Position) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 12,326,018 13.900% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 12,326,018 13.900% | -209,197 (-1.67%) | Filing History |
| 2023-01-10 08:47 am Sale | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 3,094,500 4.410% | -892,370 (-22.38%) | Filing History |
| 2023-01-10 08:35 am Sale | 2022-12-31 | 13G | Omega Alpha SPAC OMEG | FEDERATED HERMES INC. FHI | 0 0.000% | -1,000,000 (Position Closed) | Filing History |